This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07100/identifier/pubchem-compound/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07100/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/drug/DB07100/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB07100/identifier/chemspider/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://linked.opendata.cz/resource/drugbank/drug/DB07100/identifier/pdb/

Statements

Subject Item
n2:DB07100
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n10:DB07100 n13:DB07100
dcterms:title
4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
adms:identifier
n4:DB07100 n7:4BH n8:20136269 n11:9796161 n12:99443571
n5:IUPAC-Name
n6:271B49D4-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B49DA-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B49D9-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B49D6-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B49D7-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B49D8-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B49D2-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B49D3-363D-11E5-9242-09173F13E4C5 n6:271B49D0-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B49D1-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B49E0-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B49E1-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B49DB-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B49DC-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B49DE-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B49DD-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B49DF-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B49E6-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B49E8-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B49E9-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B49E5-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B49E4-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B49E7-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B49D5-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B49E2-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B49E3-363D-11E5-9242-09173F13E4C5